The present invention provides solid oral pharmaceutical compositions comprising combination of metformin and sitagliptin or salts thereof. In particular, the present invention relates to a pharmaceutical composition comprising metformin and sitagliptin or salts thereof which is devoid of any surface active agents. The invention also includes process of preparing such compositions and method of use of such compositions for treating type II diabetes.